Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
Study probes perceptions, attitudes of oncologists' drug therapy choices
July 28th, 2005
Market Strategies, Inc. (MSI), a syndicated research and strategic consulting firm, recently announced findings from its annual analysis of oncologists' perceptions and attitudes at ASCO 2005 (American Society of Clinical Oncology). The research was conducted by MSI's Global Life Sciences division and is based on responses from 101 oncologists who attended ASCO. The findings indicate that nearly two-thirds of physicians predict increased use of Herceptin for treatment of adjuvant breast cancer as a result of data presented at ASCO 2005, and more than half of the oncologists indicated feeling similarly about Avastin for treatment of non-small cell lung cancer. ...
Source: Women's Health Weekly (2005-07-28)
|
